Intrafractional and Interfractional Range Variation in Charged Particle Therapy of Lung Cancer

Reviewer: Geoffrey Geiger MD
Abramson Cancer Center of the University of Pennsylvania
Ultima Vez Modificado: 14 de octubre del 2009

Translation for this article does not exist


Where Are the Adults in the Room?
by Rodney Warner, JD
November 20, 2015

Related News

More Evidence Needed on Charged-Particle Therapy

Nov 24, 2015

Research scarce on comparative effectiveness, safety of charged-particle therapy for cancer

ASCO: New Advanced Lung Cancer Treatments Promising

Nov 24, 2015

But hormone therapy among menopausal women with lung cancer linked to higher risk of death

ASCO: Anti-PD-1 Antibody Active Against Various Cancers

Jun 5, 2012

Immunotherapy with BMS-936558 has antitumor activity in melanoma, NSCLC, renal cell cancer